#AAPP2026 Spotlight: Intended And Unintended Outcomes After FDA Pediatric Antidepressant Warnings, presented by Stephen Soumerai, ScD.
This session will examine the clinical trial data that prompted the warnings, evaluate both the safety intentions and unintended consequences on prescribing patterns and patient outcomes, and highlight future research needed to clarify risks and inform evidence-based practice. Join us at the 2026 AAPP Annual Meeting in Bellevue, WA, on Seattle’s Eastside, for this session!
#AAPP #psychpharmacy #acpe #bcpp #bcpmp